Zentalis Pharmaceuticals Inc

Fermé

3.95 2.86

Résumé

Variation du prix de l'action

24h

Actuel

Min

3.76

Max

4.03

Chiffres clés

By Trading Economics

Revenu

-136K

-35M

BPA

-0.503

Employés

106

EBITDA

2.2M

-35M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+76.32% upside

Dividendes

By Acuity

Prochains Résultats

4 août 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-33M

261M

Ouverture précédente

1.09

Clôture précédente

3.95

Zentalis Pharmaceuticals Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

25 juin 2026, 23:56 UTC

ETF Constituents
Correlated Moves
Macro News

The Consumer Discretionary Select Sector SPDR Fund declined after the U.S. core PCE price index rose, exceeding the Federal Reserve's target and impacting sentiment.

25 juin 2026, 23:56 UTC

Gilead Sciences shares moved higher in after-market hours, despite earlier declines during regular trading amid mixed U.S. market performance influenced by economic data.

25 juin 2026, 23:52 UTC

U.S. equity markets show mixed results amid inflation concerns and stronger-than-expected GDP growth, while the dollar strengthens as Treasury yields drive forex dynamics.

25 juin 2026, 23:52 UTC

European equity markets rise on strong tech earnings, while UK retail struggles and France sees improved consumer confidence amidst mixed economic signals.

25 juin 2026, 23:52 UTC

Global markets show mixed performance as U.S. tech stocks lag despite strong job data and GDP growth, while Japan's Nikkei rises on positive earnings.

25 juin 2026, 23:52 UTC

Mixed Asia equity markets as Japan's Nikkei rises 4.3% on strong tech earnings, while U.S. jobless claims drop and GDP growth is revised up, amid persistent inflation concerns.

25 juin 2026, 23:52 UTC

Macro News

The Nikkei 225 Index is lower in after-market hours amid yen weakness and rising geopolitical tensions affecting investor sentiment.

25 juin 2026, 23:51 UTC

Incyte Corp shares are higher in after-market hours, recovering from an earlier session low. Broader market performance remains mixed amid varying tech stock results.

25 juin 2026, 23:51 UTC

Monster Beverage Corp. shares are lower in after-market trading, continuing a decline since Thursday's close, despite remaining above the 20-day moving average.

25 juin 2026, 23:51 UTC

Electronic Arts Inc. shares are lower in after-market trading amid notable weakness in the Interactive Home Entertainment sub-sector. No specific news was identified.

25 juin 2026, 23:51 UTC

Charter Communications Inc shares are higher in after-market hours, recovering from an earlier dip. The stock remains below its 20-day moving average.

25 juin 2026, 23:51 UTC

Market Anticipates Positive Job Growth in Upcoming ADP Employment Report Amid Optimistic Labor Market Sentiment and Inflation Concerns.

25 juin 2026, 23:51 UTC

American Airlines shares are lower in after-market hours, with no specific news identified. The broader market showed mixed performance following Thursday's close.

25 juin 2026, 23:51 UTC

Correlated Moves
Macro News

The S&P 500 Index is lower today amid a securities fraud lawsuit against Zillow and rising geopolitical tensions affecting market sentiment.

25 juin 2026, 23:51 UTC

Workday Inc shares are higher in after-market trading, driven by gains in the Application Software sub-sector. The stock has recovered from earlier lows.

25 juin 2026, 23:51 UTC

Correlated Moves
Social Media

Applied Materials shares are higher in after-market hours following Citi's price target increase to 710 and positive sentiment in the semiconductor equipment sector.

25 juin 2026, 23:51 UTC

News

Crude oil prices rise amid escalating Middle East tensions after a projectile strike near Oman. The United States Oil Fund LP is slightly higher after hours.

25 juin 2026, 23:51 UTC

ETF Constituents

iShares Biotechnology ETF is higher in after-market trading, supported by gains from Vertex Pharmaceuticals, Gilead Sciences, and Incyte Corporation among others.

25 juin 2026, 23:51 UTC

T-Mobile US Inc shares are higher in after-market hours, showing unusual strength amid mixed broader market performance with no specific news identified.

25 juin 2026, 23:51 UTC

Social Media
Correlated Moves
News

Qualcomm is in talks to acquire Modular for $4 billion. Shares are trading lower after the company's optimistic revenue targets and Investor Day updates.

25 juin 2026, 23:51 UTC

Social Media
News

Micron Technology Inc. shares fell in after-market trading despite a 350% year-over-year revenue increase, amid broader tech sector weakness.

25 juin 2026, 23:51 UTC

The EUR/HUF is lower in Thursday's session amid ongoing market volatility. The currency pair briefly gained before declining without a specific identified driver.

25 juin 2026, 23:51 UTC

Correlated Moves

Ethereum is trading lower, continuing a four-session decline amid significant volatility. It remains under pressure, well below its 20-day moving average.

25 juin 2026, 23:51 UTC

Social Media
Correlated Moves

Broadcom Inc. shares were roughly flat in after-market trading, continuing a trend of decline this month, contrasting with gains among other large S&P 500 stocks.

25 juin 2026, 23:51 UTC

NetEase Inc shares are higher in after-market hours following Thursday's close, despite remaining below the 20-day moving average. No specific news was identified.

25 juin 2026, 23:46 UTC

Correlated Moves

Vanguard Total International Bond ETF trades near unchanged after hours, reflecting stable performance amid slight declines in the US 10Y Treasury Bond.

25 juin 2026, 23:46 UTC

Correlated Moves

iShares TIPS Bond ETF remains flat in after-hours trading, reflecting stability amid a slight increase in the iShares iBoxx $ High Yield Corporate Bond ETF.

25 juin 2026, 23:46 UTC

ETF Constituents
Correlated Moves

Health Care Select Sector SPDR Fund declines in after-market hours, reflecting broader market trends. Key holdings Zoetis and Baxter contribute negatively to performance.

25 juin 2026, 23:46 UTC

SPDR Gold Shares are trading lower in after-market hours, remaining below the 20-day moving average and near the lower end of its one-month trading range.

25 juin 2026, 23:46 UTC

PayPal Holdings Inc shares are higher in after-market trading, influenced by strong earnings from Micron Technology amid a mixed tech sector performance.

Comparaison

Variation de prix

Zentalis Pharmaceuticals Inc prévision

Objectif de Prix

By TipRanks

76.32% hausse

Prévisions sur 12 Mois

Moyen 7 USD  76.32%

Haut 10 USD

Bas 4 USD

Basé sur 7 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

7 ratings

4

Achat

3

Maintien

0

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Zentalis Pharmaceuticals Inc

Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its products candidatures include the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase for the treatment of inhibitor for advanced solid tumors and hematological malignancies; in Phase 2 clinical trial as a monotherapy for the treatment of uterine serous carcinoma indications; Phase 2 clinical trial in Cyclin E1 driven high-grade serous ovarian cancer, fallopian tube, or primary peritoneal cancer; Phase 1/2 clinical trial in combination with PARPi for platinum-resistant ovarian cancer; Phase 1b clinical trial in combination with chemotherapy in platinum-resistant ovarian, and peritoneal or fallopian tube cancer; Phase 1/2 clinical trial in combination with chemotherapy in relapsed or refractory osteosarcoma; Phase 1/2 clinical trial with encorafenib and cetuximab for mutant metastatic colorectal cancer; and Phase 1/2 clinical trial in combination with chemotherapy in pancreatic cancer. The company's products pipeline also includes ZN-d5, an oral small molecule inhibitor of B-cell lymphoma 2, for hematological malignancies and related disorders; and BCL-xL heterobifunctional degrader, a member of the anti-apoptotic BCL-2 proteins, for solid tumors and hematological malignancies. Zentalis Pharmaceuticals, Inc. has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC; Pfizer, Inc.; Zentera Therapeutics; Dana-Farber; and GlaxoSmithKline plc. The company was incorporated in 2014 and is headquartered in New York, New York.
help-icon Live chat